여성형 유방 수술 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Gynecomastia Procedures Market was valued at USD 1 billion in 2025 and is estimated to grow at a CAGR of 8.6% to reach USD 2.3 billion by 2035.

Market momentum is supported by the growing incidence of obesity, a rising population of men experiencing hormonal irregularities, and continuous technological innovation in surgical techniques. Higher body fat levels are closely linked to endocrine disruption, particularly elevated estrogen activity resulting from adipose tissue metabolism, which significantly increases the likelihood of gynecomastia. In addition, excess fat accumulation in the chest region often leads patients to pursue corrective procedures for both medical and aesthetic improvement. The expanding burden of obesity, combined with greater awareness, improved diagnosis rates, and broader social acceptance of male aesthetic procedures, is translating into sustained procedural demand worldwide. Advancements in minimally invasive technologies and enhanced surgical precision are further strengthening patient confidence and long-term treatment adoption across key markets.

By procedure type, the market is categorized into liposuction and excision, with the excision segment generating USD 558.7 million in 2025 and accounting for a substantial share. Excision procedures involve the precise removal of glandular breast tissue through carefully placed incisions, enabling effective correction in cases where dense tissue cannot be addressed through fat removal techniques alone. This method provides reliable contouring outcomes and is particularly suited for moderate to advanced presentations. Its clinical effectiveness and ability to deliver permanent tissue removal continue to drive adoption across surgical practices.

In terms of end use, the cosmetic surgical centers segment captured 62.9% share in 2025. These facilities are specifically structured to deliver elective aesthetic procedures, offering specialized expertise, advanced equipment, and experienced surgical teams focused on male breast reduction treatments. Their operational efficiency supports higher patient throughput and consistent results. Compared to hospital settings, cosmetic surgical centers generally provide shorter scheduling timelines, competitive pricing structures, and streamlined care delivery models. These advantages strongly appeal to self-funded patients, who represent a significant portion of individuals seeking gynecomastia correction.

Regionally, North America accounted for more than 40.5% of the global gynecomastia procedures industry share in 2025. Growth across the U.S. market is largely fueled by the high prevalence of obesity and increasing recognition of gynecomastia as a manageable medical and cosmetic concern. Broader education initiatives, expanded consultation access, and digital health engagement have encouraged more men to pursue professional treatment. Evolving perceptions surrounding male wellness and physical appearance continue to support procedural uptake throughout the region.

Key companies active in the Global Gynecomastia Procedures Market include Johnson & Johnson, AbbVie Inc., Candela Corporation, Cutera, Lumenis, Cynosure, Solta Medical, Sientra, MicroAire Surgical Instruments, and Aesthetic Group. Companies operating in the Gynecomastia Procedures Market are strengthening their competitive position through innovation, portfolio expansion, and strategic collaborations. Leading players are investing heavily in advanced surgical technologies that improve precision, reduce recovery time, and enhance patient outcomes. Many firms are broadening their aesthetic device portfolios to address evolving clinical preferences and surgeon demand. Partnerships with cosmetic surgical centers and specialty clinics are helping manufacturers expand distribution networks and increase product visibility. Organizations are also prioritizing physician training programs and hands-on workshops to build brand loyalty and encourage product adoption. In addition, mergers, acquisitions, and geographic expansion strategies are being implemented to reinforce global presence and capture emerging growth opportunities.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Procedure type trends
  • 2.2.2 Age group trends
  • 2.2.3 End use trends
  • 2.2.4 Regional trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of obesity
    • 3.2.1.2 Rising number of men affected by hormonal imbalances
    • 3.2.1.3 Upsurge in technological advancements
    • 3.2.1.4 Increasing awareness regarding gynecomastia
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of procedures
    • 3.2.2.2 Lack of reimbursement scenario
  • 3.2.3 Market opportunities
    • 3.2.3.1 Rising demand for minimally invasive procedures
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard
• 4.7 Key developments
  • 4.7.1 Mergers and acquisitions
  • 4.7.2 Partnerships and collaborations
  • 4.7.3 New product launches
  • 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Procedure Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Liposuction
• 5.3 Excision

Chapter 6 Market Estimates and Forecast, By Age Group, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 18-40 years
• 6.3 Above 40 years

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Cosmetic surgical centers
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.4 Italy
  • 8.3.5 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 MicroAire Surgical Instruments
• 9.2 Lumenis
• 9.3 Aesthetic Group
• 9.4 Candela Corporation
• 9.5 Johnson & Johnson
• 9.6 Cutera
• 9.7 Cynosure (Hologic, Inc.)
• 9.8 AbbVie Inc.
• 9.9 Solta Medical
• 9.10 Sientra